Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
In cases where metformin is not suitable or not sufficient to achieve target blood glucose levels, healthcare providers may consider adding or switching to other medications, such as GLP-1s, DPP-4 inhibitors, SGLT-2 inhibitors, or insulin
Berberine in the Treatment of Neurodegenerative Diseases and Nanotechnology Enabled Targeted Delivery
Certain amounts are permissible under the law as long as the compounding is not done regularly or in inordinate amounts. Section 503B of the FD&C Act restricts outsourcing facilities from making compounded drugs that are essentially a copy of one or more FDA-approved drugs
Novel role of 4-hydroxy-2-nonenal in AIFm2-mediated mitochondrial stress signaling
US$ 23.77
US$ 24.63
US$ 22.73
US$ 24.56
